**Question:** Following statements regarding verapamil are true except:

A. Verapamil is a calcium channel blocker that competitively inhibits the influx of calcium ions across cell membranes, leading to decreased intracellular calcium concentrations and subsequent relaxation of vascular smooth muscles.
B. Verapamil is a beta-adrenergic antagonist, which competes with catecholamines for binding to beta receptors, thereby reducing the effect of catecholamines on heart rate and contractility.
C. Verapamil has significant affinity for alpha-adrenergic receptors, leading to vasodilation and decreased blood pressure.
D. Verapamil is a potent inhibitor of the sodium channel, reducing the availability of sodium ions for entry into cardiac and smooth muscle cells, causing hypotension and bradycardia.

**Core Concept:**
Verapamil is a calcium channel blocker, which competitively inhibits the influx of calcium ions across cell membranes, primarily affecting cardiac and vascular systems. By decreasing intracellular calcium concentrations, verapamil causes relaxation of vascular smooth muscles and inhibits the contraction and conduction of cardiac muscle cells. Verapamil is not a beta-adrenergic antagonist, alpha-adrenergic agonist, or sodium channel inhibitor.

**Why the Correct Answer is Right:**

D. Verapamil is a potent inhibitor of the sodium channel, reducing the availability of sodium ions for entry into cardiac and smooth muscle cells. This would lead to hypotension and bradycardia, which is not mentioned in the given options. Verapamil primarily affects calcium channels, not sodium channels.

**Why Each Wrong Option is Incorrect:**

A. Verapamil is a calcium channel blocker, but it does not competitively inhibit the influx of calcium ions across cell membranes. Verapamil primarily acts on cardiac and vascular systems.
B. Verapamil does not have significant affinity for alpha-adrenergic receptors. It is a calcium channel blocker, not an antagonist of beta-adrenergic receptors.
C. Verapamil does not have significant affinity for alpha-adrenergic agonist effects. It is a calcium channel blocker, affecting cardiac and vascular systems.

**Clinical Pearl:**

Verapamil is a potent antiarrhythmic drug used for the management of various cardiac arrhythmias, angina pectoris, and hypertension. It is essential to understand the correct mechanism of action and clinical indications of verapamil to effectively prescribe and monitor its use.

**Why Core Concept is Relevant:**

Verapamil's primary mechanism involves blocking calcium channels, which is crucial for understanding its pharmacodynamics and pharmacokinetics. Understanding the correct mechanism helps in therapeutic decision-making and predicting potential side effects and drug interactions.